Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA001328 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA001328, RRID:AB_1078296
- Product name
- Anti-BRAF
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human BRAF, Gene description: B-Raf proto-oncogene, serine/threonine kinase, Alternative Gene Names: BRAF1, Validated applications: IHC, WB, Uniprot ID: P15056, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation
The yin–yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF
Clinical characteristics and molecular pathology of skull ectopic thyroid cancer
Tuneable endogenous mammalian target complementation via multiplexed plasmid-based recombineering
Jasani N, Xu X, Posorske B, Kim Y, Vera O, Tsai K, DeNicola G, Karreth F
2024
2024
ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
Su W, Mukherjee R, Yaeger R, Son J, Xu J, Na N, Merna Timaul N, Hechtman J, Paroder V, Lin M, Mattar M, Qiu J, Chang Q, Zhao H, Zhang J, Little M, Adachi Y, Han S, Taylor B, Ebi H, Abdel-Wahab O, de Stanchina E, Rudin C, Jänne P, McCormick F, Yao Z, Rosen N
Molecular Cell 2022;82(13):2443-2457.e7
Molecular Cell 2022;82(13):2443-2457.e7
Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation
Zheng L, Yan X, Hu C, Zhang P, Chen Y, Zheng Q, Hu L, Wang M, Li G, Wu P, Jiang C, Tian J, Zhang S, Wang X
Frontiers in Endocrinology 2022;13
Frontiers in Endocrinology 2022;13
The yin–yang of kinase activation and unfolding explains the peculiarity of Val600 in the activation segment of BRAF
Kiel C, Benisty H, Lloréns-Rico V, Serrano L
eLife 2016;5
eLife 2016;5
Clinical characteristics and molecular pathology of skull ectopic thyroid cancer
Cao L, Wang Z, Ma J, Chen J, Zhu H, Zhou X, Zhu Q, Dong J, Lan Q, Huang Q
Annals of Translational Medicine 2016;4(23):462-462
Annals of Translational Medicine 2016;4(23):462-462
Tuneable endogenous mammalian target complementation via multiplexed plasmid-based recombineering
Beltran-Sastre V, Benisty H, Burnier J, Berger I, Serrano L, Kiel C
Scientific Reports 2015;5(1)
Scientific Reports 2015;5(1)
No comments: Submit comment
No validations: Submit validation data